retinal microvascular pericytes
Recently Published Documents


TOTAL DOCUMENTS

15
(FIVE YEARS 2)

H-INDEX

6
(FIVE YEARS 0)

2021 ◽  
Vol 2021 ◽  
pp. 1-10
Author(s):  
Tianye Yang ◽  
Liang Guo ◽  
Yuan Fang ◽  
Mingli Liang ◽  
Yongzheng Zheng ◽  
...  

Inner blood-retina barrier (iBRB) is primarily formed of retinal microvascular endothelial cells (ECs) with tight junctions, which are surrounded and supported by retinal microvascular pericytes (RMPs) and basement membrane. Pericytes are believed to be critically involved in the physiology and pathology of iBRB. However, the underlying mechanism remains to be fully elucidated. We developed a novel in vitro iBRB model which was composed of primary cultures of rat retinal ECs and RMPs based on Transwell system. We tested the involvement of pericytes in the migration and invasion of ECs, examined the expression and activity of matrix metalloproteinase- (MMP-) 2/MMP-9 in the culture, evaluated the TEER and permeability of iBRB, and assessed the expression of ZO-1, occludin, claudin-5, and VE-cadherin of endothelial junctions. We found that RMPs with indirect contact of ECs can increase the expression of MMP-2 and upgrade the activity of MMP-2/9 in the coculture, which subsequently decreased TJ protein abundance of ZO-1 and occludin in ECs, promoted the migration of ECs, and finally reduced the integrity of iBRB. Taken together, our data show that RMP relative location with ECs is involved in the integrity of iBRB via MMP-2/9 and has important implications for treating diabetic retinopathy and other retinal disorders involving iBRB dysfunction.


2014 ◽  
Vol 21 (6) ◽  
pp. 478-489 ◽  
Author(s):  
Guanghui Liu ◽  
Chun Meng ◽  
Mingdong Pan ◽  
Meng Chen ◽  
Ruzhi Deng ◽  
...  

2014 ◽  
Vol 396 (1-2) ◽  
pp. 239-248 ◽  
Author(s):  
Kaihong Zeng ◽  
Jian Ming ◽  
Na Yang ◽  
Jing Wang ◽  
Xuemei Yu ◽  
...  

2002 ◽  
Vol 282 (2) ◽  
pp. H739-H748 ◽  
Author(s):  
Jose A. Nadal ◽  
G. M. Scicli ◽  
L. A. Carbini ◽  
A. Guillermo Scicli

We studied the promigratory effect of angiotensin II (ANG II) on cultured bovine retinal microvascular pericytes. ANG II stimulated migration of pericytes by 86% at 10−8 M, but this effect was lost at 10−4M. Migratory responses were inhibited by the ANG II type 1 (AT1) receptor antagonist losartan but not by PD-123319, an AT2 antagonist. Addition of PD-123319 to the 10−4 M ANG II dose restored migratory responses. The promigratory effect of ANG II (10−7 M) was reduced by 59% in absence of gradient. Although ANG II augmented the latent matrix metalloproteinase-2 (MMP-2) activity of the pericyte by 35%, it also doubled tissue inhibitors of MMPs. ANG II-induced migration was not altered by a broad-spectrum MMP inhibitor (GM6001); it was inhibited by ∼50% by antibodies against transforming growth factor (TGF)-β1/2/3 and was abolished by antibodies against platelet-derived growth factor (PDGF)-BB. We conclude that ANG II induces chemotactic responses on retinal microvascular pericytes acting through the AT1 receptor. This effect is opposed by the AT2 receptor. ANG II-induced chemotaxis is mediated by PDGF-BB and involves TGF-β, but it is independent of MMP activity. It is also independent of vascular endothelial growth factor (VEGF) because VEGF did not stimulate pericyte migration. ANG II can contribute to the regulation of retinal neovascularization by stimulating pericyte migration.


2000 ◽  
Vol 71 (3) ◽  
pp. 309-315 ◽  
Author(s):  
K Naruse ◽  
J Nakamura ◽  
Y Hamada ◽  
M Nakayama ◽  
S Chaya ◽  
...  

Sign in / Sign up

Export Citation Format

Share Document